Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From VaxEquity Ltd
The US biotech major has unveiled plans to open a new research and manufacturing center in the UK, which signals the start of detailed talks with the government about establishing a long-term partnership.
The French drug maker isn’t moving its mRNA COVID-19 vaccine into Phase III, instead focusing on a GSK-partnered protein SARS-CoV-2 vaccine and applying mRNA technology elsewhere.
- Gene Therapy, Cell Therapy